Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether sitagliptin is effective in the treatment of reactive hypoglycemia by dysinsulinism.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Clinical and biochemical diagnosis of prediabetic reactive hypoglycemia

• Must be able to swallow tablet

• Negative pregnancy test (when appropriate)

Exclusion Criteria:

• Renal insufficiency

• Hepatic insufficiency

• Diabetes (any type)